Analysis of structural changes in the stria vascularis following chronic gentamicin treatment

Hearing Research
A ForgeS J Davies

Abstract

Changes in the stria vascularis following chronic gentamicin treatment have been examined using quantitative methods. Albino guinea pigs were given gentamicin at 100 mg.kg-1.day-1 subcutaneously for 10 days. Comparisons were made of strial tissue from the treated animals sacrificed either 1 h or 4 weeks following the last injection with that from saline-injected controls. Strial width (spiral prominence to Reissner's membrane) and marginal cell (MC) number across the stria were determined from scanning electron micrographs. Strial thickness (endolymphatic surface to spiral ligament) and the volume fractions of the strial components (MCs, intermediate cells (ICs), basal cells (BCs) and capillaries) were derived from thin sections. Qualitative changes to both MCs and ICs were apparent 1 h after the last injection. At four weeks post-treatment, there was a small, but statistically significant, decrease in the number of marginal cells and a highly significant decrease in strial thickness. This was almost entirely due to a highly significant decrease in the volume fraction of MCs (i.e. shrinkage). The volume fraction of ICs was increased but this could be accounted for by MC shrinkage; after allowing for the reduction in strial thic...Continue Reading

References

Dec 7, 2007·Journal of the Association for Research in Otolaryngology : JARO·Ruth Rebecca TaylorA Forge
Mar 4, 2009·Journal of the Association for Research in Otolaryngology : JARO·Qi Wang, P S Steyger
Aug 1, 1990·Hearing Research·P J LohuisK E Rarey
Dec 2, 2004·Auris, Nasus, Larynx·Takeshi KusunokiMichael M Paparella
Nov 6, 2003·Hearing Research·Steven SluyterGuido F Smoorenburg
Mar 9, 2013·Experimental & Molecular Medicine·Jeong-Han LeeRaekil Park
Aug 1, 2013·Indian Journal of Pharmaceutical Sciences·D WrześniokE Buszman
Feb 10, 2006·Hearing Research·C F DaiP S Steyger
Aug 19, 2015·Frontiers in Cellular Neuroscience·Chao-Hui YangJochen Schacht
Nov 1, 1988·Biological Reviews of the Cambridge Philosophical Society·J G Altin, F L Bygrave
Sep 8, 2017·Frontiers in Cellular Neuroscience·Shimon P Francis, Lisa L Cunningham

Citations

Nov 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P A Santi, D C Muchow
Jul 1, 1987·Journal of Microscopy·S Davies, A Forge
Jan 1, 1987·ORL; Journal for Oto-rhino-laryngology and Its Related Specialties·S KomuneT Morimitsu
Jan 1, 1987·Hearing Research·K P SteelG R Bock
Sep 1, 1973·Audiology : Official Organ of the International Society of Audiology·E Hawkins
Mar 1, 1972·The Laryngoscope·M Mendelsohn, I Katzenberg
Jun 1, 1982·Archives of Otolaryngology·S Komune, J B Snow

Related Concepts

Albinism
Gentavet
Gentamicins
Cavia
Subcutaneous Injections
Gentacycol
Basilar Papilla
Stria
Cell Density
Gentamicin Measurement

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.